The ablation devices segments are further sub segmented based on product types as follows - electrical (electrosurgical ablator devices and electrical brachytherapy devices), radiation (brachytherapy, stereotactic radio surgery devices, stereotactic body radiotherapy devices, image guided radiotherapy (IGRT), image modulated radiotherapy (IMRT), nano radiation therapy, proton beam therapy), radiofrequency (temperature controlled devices, fluid cooled, catheter manipulation systems), light (cold lasers, excimer lasers, photonic ablation devices, ultraviolet lasers and others), cryotherapy (cardiac cryoablation devices and cryospray
ablation systems), microwave (coretherm thermotherapy devices and prolieve thermotherapy devices).
develops and manufactures a proprietary therapeutic interventional platform, the CryoSpray
Ablation(TM) System, comprised of a device, specialty catheters and agent that allow delivery of therapeutic doses of a cryogen to flash freeze and destroy diseased tissue inside the body.
Based in Baltimore, MD, CSA Medical recently partnered with a leading CM to manufacture its CryoSpray Ablation system.
Following eight years of invention, testing, product development and clinical trials, the CryoSpray Ablation system is in production at Solectron's Charlotte, NC facility.
ablation was suggested as an alternative by the article.
CSA Medical, Inc develops and manufactures a proprietary therapeutic interventional treatment platform, the CryoSpray
Ablation(TM) System, that delivers therapeutic doses of a cryogen to flash freeze and destroy diseased tissue inside the body.
Solectron Corporation (NYSE:SLR), a leading provider of integrated electronic supply chain services including design, manufacturing and aftermarket services, has finalized an agreement with CSA Medical to manufacture the company's CryoSpray Ablation(TM) system.
Based in Baltimore, MD, CSA Medical developed the CryoSpray Ablation system, which freezes and destroys unwanted tissues found in the esophagus, which, according to various reports arises from chronic acid reflux.
manufacturer of the CryoSpray
Ablation system, announced today the official launch of its newly redesigned Web site (http://www.
He will be responsible for ensuring growth in the number of CryoSpray
Ablation procedures performed by institutions and physicians currently using the CSA System.
CSA Medical has seen impressive growth since commercially launching the CryoSpray
product in May 2007.
s endoscopic cryospray
ablation (CSA) tool for use worldwide in the treatment of cancers and other diseases of the chest, lungs, and airway.